In-Vitro Diagnostics Market Analysis to 2017
RNCOS has recently added a new Market Research Report titled, “In-Vitro Diagnostics Market Analysis to 2017” to its report gallery
In their latest research study, “In-Vitro Diagnostics Market Analysis to 2017”, RNCOS analysts identified market dynamics in various important regions to highlight the areas offering promising possibilities for companies to boost their growth. The market, which stood at US$ 52.4 Billion in 2012, is expected to grow at a CAGR of 7% during 2012-2017.
In the report, the IVD market has been studied on three distinct levels: Regional, Clinical and Player level. For regional analysis, key IVD markets that together constitute around 95% of the global market, have been profiled. Further, the market has been divided into eight distinct clinical segments and their current and future outlook to 2017 has been analyzed. Through this, our analysts have conducted a thorough opportunity assessment in various clinical segments and highlighted the clinical segments that offer the maximum opportunity for growth in each region.
Besides, our team has also analyzed the revenue generated from each clinical segment to recognize key segments that offer very high growth rates. The study further delves into the business dynamics of major players in the industry that together form around 80% of the global IVD market. To provide a thorough understanding of the Company's business model, Company's current and historical financials have been analyzed. Also, the Company's revenue from IVD has been depicted with a further breakup by clinical segment. The study also portrays each Company's strengths and weaknesses that will help the reader to better position its company vis-à-vis competition.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM472.htm
Some of our Related Reports are:
- US Telelaparoscopy Opportunity Analysis (http://www.rncos.com/Report/IM469.htm)
- US Proton Therapy Market Analysis to 2017 (http://www.rncos.com/Report/IM465.htm)
- US Personalized Cancer Genome Sequencing Market (http://www.rncos.com/Report/IM453.htm)
- Brazil Healthcare - New Opportunities for Growth (http://www.rncos.com/Report/IM451.htm)
- US Non-Invasive Prenatal Diagnostics - Market Insight (http://www.rncos.com/Report/IM450.htm)
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
B-129, Sector 6 Noida - 201301
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release In-Vitro Diagnostics Market Analysis to 2017 here
News-ID: 252579 • Views: 2380
More Releases from RNCOS E-Services Pvt. Ltd.
Malaysia Convenience Store Witnessing Tremendous Growth
“Rapid expansion plans of major convenience stores in Malaysia such as 7-Eleve and 99 Speed Mart are expected to drive the market.” says RNCOS Malaysia Convenience store has been witnessing a tremendous growth in the retail industry. Key players in the country are widening their foot prints in retail industry by innovatively increasing the product portfolio as per the consumer behavior and increasing the number of stores. There is a cut
Growing Opportunity in the Global Enterprise Software Market
“Increasing adoption of enterprise resource management software, customer relationship management software and human resource management software is expected to drive the Global Enterprise Software market.” Says RNCOS The global enterprise software market has reported a significant growth in the recent years and is presenting ample opportunities to the industry’s players. With increasing global competition and rising awareness regarding enterprises software across the globe, the worldwide enterprise software market is poised to
Global Wearable Medical Device Market Outlook 2020
By wearable medical devices we understand non-invasive, autonomous health tools, which aid in clinical monitoring beyond the hospitals. The application of wearable ranges from monitoring glucose levels in blood to managing chronic diseases such as heart diseases, asthma and diabetes. These devices generally provide non-invasive sensing, local processing, user feedback, and communication capabilities. In the latest report “Global Wearable Medical Device Market Outlook 2020”, RNCOS’ analysts have endeavored to
Global Point-of-Care Diagnostics Market Outlook 2020
It is widely accepted that disease prevention and risk-reduction strategies have the potential to lower disease burden as well as improve the overall health of individuals. POCT technology offers such potential for diagnosis and treatment of patients, as it facilitates rapid availability of test results and hence, early clinical decision making and intervention. Amidst a rising disease incidence, reduced budget, growing focus towards personalization of care, and ever-increasing integration of
More Releases for Diagnostics
Transplant Diagnostics Market
Transplant diagnostics is the examination of factors associated with recently performed transplant. This can be elaborated as safety testing, compatibility, testing, transplant feasibility testing, pre, peri, and post transplantation. This is done to check the tissue compatibility between the donor and patient in organ transplant. Major Players: The prominent players in the transplant diagnostics market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Illumina, Inc., Merck KGaA,
Demand for Rapid Diagnostics Tests Trending the Pneumonia Diagnostics Market
The World Health Organization estimates that pneumonia accounted for 16% of all deaths of children below the age of 5 years – more than 920,000 in 2015. The WHO states that the cost of pneumonia antibiotic treatment in the same year for child survival and newly born babies is roughly US$ 110 million annually. Therefore, there is a pressing need to analyse the pneumonia diagnostics market. In an upcoming report
Europe Transplant Diagnostics Market
The Europe Transplant Diagnostics Market Report is an upcoming report from Data Bridge Market Research. The new market report contains data for historic years 2015, the base year of calculation is 2017 and the forecast period is 2018 to 2025. Transplant diagnostics are the diagnostics tests performed while relocating organ in order to treat organ failure such as liver, pancreas, lungs, kidney, and heart. These tests are widely performed by skilled
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about
Global Influenza Diagnostics Market 2017 : BioMerieux, SA Scientific, Enigma Dia …
Influenza Diagnostics Market 2017 A market study based on the " Influenza Diagnostics Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Influenza Diagnostics Market 2017’. The research report analyses the historical as well as present performance of the worldwide Influenza Diagnostics industry, and makes predictions on the future status of Influenza Diagnostics market on the basis of this analysis. Get Free Sample Copy of
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test